OptimizeRx (OPRX) Interest Expenses (2010 - 2026)

OptimizeRx's Interest Expenses history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 10.95% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.2 million (down 12.84% YoY), while the FY2025 annual figure was $5.3 million, down 14.06% from the prior year.
• Interest Expenses came in at $1.2 million for Q1 2026 at OptimizeRx, down from $1.2 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.6 million in Q2 2025 to a low of $1.2 million in Q3 2025.
• A 3-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 4.91% in 2025 and fell as far as 24.28% in 2025.
• OptimizeRx's Interest Expenses stood at $1.6 million in 2024, then fell by 20.6% to $1.2 million in 2025, then retreated by 6.93% to $1.2 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $1.2 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison